The emerging evidences supported that KDMs such as KDM3A, KDM5C, KDM6A, and KDM6B play important roles in RCC, and KDMs could promote RCC development and progression via hypoxia-mediated angiogenesis pathways (Guo and Zhang, 2017). This evidence concerns the gene KDM5C and renal cell carcinoma.